Skip to Main Content

Paper Details

Final results of a phase 2 clinical trial of LCL161, an oral SMAC mimetic for patients with myelofibrosis.
Blood Adv
14
2021
Author NameAffiliation
Guillermo Garcia-Manero
Courtney D DiNardo
Gautam Borthakur
Qingyi WeiMD Anderson Cancer Center
Jorge CortesGeorgia Cancer Center, Augusta University
  • 1 - 5

Datasets

Release 1.2